BSLN fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000, and is headquartered in Allschwil, Switzerland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
BSLN has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company